Key Points
OPTN mediates protection from HSV-2 by regulating the intrinsic immune response.
OPTN loss results in hyperproliferation of HSV-2 and reduced CCL5 induction.
OPTN/CCL5 nexus restricts hyperproliferative spread of primary HSV-2 infection.
Abstract
Very little knowledge exists on virus-specific host cell intrinsic mechanisms that prevent hyperproliferation of primary HSV type 2 (HSV-2) genital infections. In this study, we provide evidence that the Nemo-related protein, optineurin (OPTN), plays a key role in restricting HSV-2 infection both in vitro and in vivo. Contrary to previous reports regarding the proviral role of OPTN during Sendai virus infection, we demonstrate that lack of OPTN in cells causes enhanced virus production. OPTN deficiency negatively affects the host autophagy response and results in a marked reduction of CCL5 induction. OPTN knockout (OPTN−/−) mice display exacerbated genital disease and dysregulated T cell frequencies in infected tissues and lymph nodes. A human transcriptomic profile dataset provides further credence that a strong positive correlation exists between CCL5 upregulation and OPTN expression during HSV-2 genital infection. Our findings underscore a previously unknown OPTN/CCL5 nexus that restricts hyperproliferative spread of primary HSV-2 infection, which may constitute an intrinsic host defense mechanism against herpesviruses in general.
Footnotes
This work was supported by National Institutes of Health Grants R01EY024710 (D.S.), R01AI1397686 (D.S.), and Departmental Core Grant P30EY001792 (D.S.).
The online version of this article contains supplemental material.
Abbreviations used in this article
- dpi
- day postinfection
- FSC
- front light scatter
- GEO
- Gene Expression Omnibus
- hpi
- hour postinfection
- HSV-2
- HSV type 2
- MOI
- multiplicity of infection
- OPTN
- optineurin
- OPTN−/−
- OPTN knockout
- qRT-PCR
- real-time quantitative PCR
- siRNA
- short interfering RNA
- Received May 20, 2021.
- Accepted October 22, 2021.
- Copyright © 2021 by The American Association of Immunologists, Inc.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.